Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) – 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS3018 Category:

OVERVIEW

Amid the coronavirus pandemic, the global market for the supply of respiratory drugs is expected to grow over the forecast period at a CAGR of 5.9%. Growth in this market is driven primarily by growing preference for the drug delivery pulmonary path, growing technological advances in the form of smart / digital inhalers and rising incidences of respiratory disorders such as COPD, asthma, and cystic fibrosis. The report discusses in detail the impact of COVID-19 on market for the year 2020 and beyond.

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 1

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 2

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 3

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 4

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 5

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 6

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 7

Pulmonary/ Respiratory Drug Delivery Market by End User (Homecare, Hospitals), Formulation Type (Suspension, Solution, Dry powder), Device Type (Dry Powder, Metered dose, Nebulizer), Canister (Coated, Plain), Applications (COPD) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Pulmonary/ Respiratory Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Pulmonary/ Respiratory Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Pulmonary/ Respiratory Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Pulmonary/ Respiratory Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Pulmonary/ Respiratory Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Pulmonary/ Respiratory Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Pulmonary/ Respiratory Drug Delivery Market – By Type (Market Size – &
million/billion)
8.1 Suspension Aerosol
8.2 Solution Aerosol
8.3 Dry Powder Formulation

9 Global Pulmonary/ Respiratory Drug Delivery Market – By Device Type
9.1 Metered Dose Inhalers (MDI)
9.2 Dry Powder Inhalers (DPI)
9.3 Nebulizers

10 Global Pulmonary/ Respiratory Drug Delivery Market – By Canister Type
10.1 Plain Canister
10.2 Coated Canister

11 Global Pulmonary/ Respiratory Drug Delivery Market – By Application
11.1 Asthma
11.2 COPD
11.3 Cystic Fibrosis

12 Global Pulmonary/ Respiratory Drug Delivery Market – By End User
12.1 Hospitals &Clinics
12.2 Homecare settings

13 Global Pulmonary/ Respiratory Drug Delivery Market – By Geography (Market Size – &
million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa

14 Global Pulmonary/ Respiratory Drug Delivery Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships

15 Global Pulmonary/ Respiratory Drug Delivery Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Teva Pharmaceutical Industries Ltd.
15.3 3M
15.4 Merck & Co., Inc.
15.5 Glaxosmithkline PLC
15.6 Omron Corporation
15.7 Sunovion Pharmaceuticals Inc.
15.8 Cipla Inc.
15.9 Astrazeneca PLC
15.10 Boehringer Ingelheim
15.11 Novartis AG
15.12 Company 11 & more

16 Global Pulmonary/ Respiratory Drug Delivery Market – Appendix
16.1 Sources
16.2 Abbreviations